- Filed
- May 12, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 5, 2026 | 39.58M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 39.6M sh |
| Shares Diluted | Q1 2026 · Mar 28, 2025 | 19.7M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $1.9M |
| Stock Repurchased | Q1 2026 · Mar 28, 2025 | $1.9M |
| Capex | Q1 2026 · Mar 31, 2026 | $10.4M |
| Capex restated | Q1 2026 · Mar 28, 2025 | $10.6M |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $15M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $15M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $824.9M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $812.8M |
| Cash And Equivalents restated | Q1 2026 · Mar 28, 2025 | $348.2M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $1.96B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $2.07B |
| Stockholders Equity | Q1 2026 · Mar 28, 2025 | $1.63B |
| Stockholders Equity | Q1 2026 · Dec 27, 2024 | $1.65B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $638.3M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $672.1M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $3.52B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $3.56B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $1.92B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $1.92B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $5.47B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $5.63B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$2.87 |
| Eps Diluted | Q1 2026 · Mar 28, 2025 | −$1.41 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$2.87 |
| Eps Basic | Q1 2026 · Mar 28, 2025 | −$1.41 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $210.6M |
| Sga Expense restated | Q1 2026 · Mar 28, 2025 | $114.9M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $23.2M |
| Rd Expense restated | Q1 2026 · Mar 28, 2025 | $15.3M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$113.5M |
| Net Income | Q1 2026 · Mar 28, 2025 | −$27.7M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$67M |
| Operating Income restated | Q1 2026 · Mar 28, 2025 | −$36.6M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $186.6M |
| Gross Profit restated | Q1 2026 · Mar 28, 2025 | $112.1M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $281.7M |
| Cost Of Revenue restated | Q1 2026 · Mar 28, 2025 | $95.1M |
| Revenue | Q1 2026 · Mar 31, 2026 | $468.3M |
| Revenue restated | Q1 2026 · Mar 28, 2025 | $207.2M |